Actual data needed to support potential of measuring serum TK levels

It has been brought to our attention by one of our readers that a Swedish company called AroCell is developing a new test that may have potential in monitoring for risk of prostate cancer progression. … READ MORE …

GRK5 and the aggressive growth of prostate cancer tumors

An article published on line in the Journal of Urology last Friday suggests that an enzyme known as G-protein-coupled receptor kinase 5 or GRK5 may have an important role in the regulation of the growth of prostate cancer. … READ MORE …

Oncothyreon enrolls first patient in Phase II trial of PX-866 for CRPC

Oncothyreon, Inc. has announced initiation of a Phase II clinical trial of the company’s investigational agent PX-866 in the treatment of men with chemotherapy-naïve, recurrent or metastatic, castration-resistant prostate cancer (CRPC). … READ MORE …